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AID FOR AIDS - AT LAST
The vast gulf that appeared between
proven scientific research and
government action in the 6 years since
the AIDS epidemic exploded in our
midst is at last narrowing, providing
new hope for more than 5 million South
Africans infected with the virus.
Cabinet endorsed the need for a
rollout of antiretroviral (ARV) drugs on
8 August, 2 days after the country's first
ever national AIDS conference in
Durban (3 - 6 August) drew to a close,
adding impetus to what appeared to be
a fledgling consensus view.
Hope and a willingness to work
together dominated the Durban
conference, attended by 2 500 scientists,
top government health officials, NGOs
and hardened activists.
This was best summed up in one
plenary session by the outgoing
Director General of Health, Dr Ayanda
Ntsaluba, who said, 'sometimes we
forget that there are points where we
can marshal our forces and ensure there
is affordable treatment for all'.
Ntsaluba said this was because the
public discourse had been so
dominated by differences over the scale
and speed of the ARV drugs rollout.
The first confirmation of a belated
'crossing of the Rubicon' came from
KwaZulu-Natal Health MEC, Dr Zweli
Mkhize, in his conference closing
speech, delivered on behalf of his
national superiors.
Mkhize reassured delegates that ARV
drug provision was 'no longer a matter
of if, but when'.
Cabinet supplied the 'when' just 2
days later after poring over a health and
finance task team report which included
details of undeniable successes in the
Western Cape (e.g. 83% survival rate
among 500 Khayelitsha patients who
took ARVs for a year).
Cabinet gave Health Minister, Dr
Manto Tshabalala-Msimang, who
opened the AIDS conference to
sustained heckling, until the end of this
month (September) to develop a
detailed operational plan for rolling out
ARV drugs. 
A collective sigh of relief emerged
from conference delegates when Mrs
Precious Matsotso, Head of the
Medicines Control Council (MCC),
asserted that nevirapine 'is not banned
and will not be banned'.
While the now 2-month deadline for
its manufacturer, Boehringer Ingelheim,
to meet technical regulatory conditions
upon which nevirapine was initially
registered for use in preventing mother-
to-child HIV infections remains,
Matsotso revealed that a generic
equivalent had been registered 'to
facilitate access'.
The extent of our unfolding tragedy
was illustrated by Dr Catherine Wilfert,
scientific director of the Elizabeth
Glaser Pediatric AIDS Foundation, who
said that 1 800 to 2 000 babies were born
HIV positive daily in Africa.
She said the same number of babies
were infected annually in the USA
before ARVs became available.
Wits Perinatal HIV Research Unit
chief, Dr James McIntyre, said that so
far about 3 per cent of HIV-infected
pregnant women in South Africa had
access to highly active antiretroviral
therapy (HAART). (The nevirapine
figure is closer to 40%.)
He emphasised that at the time of the
AIDS conference, South Africa
remained the only country that still
questioned the full registration of
nevirapine among 72 that had
registered the drug. 
Professor 'Slim' Abdool Karim,
scientific programme chair of the
conference, bluntly told delegates that
'South Africa without nevirapine for
mother-to-child transmission (MTCT) is
just not an option'.
Appealing for unity to resolve the
impasse, he said 'we can't solve this if
we continue disparaging and sniping at
one another'.
McIntyre agreed, adding, 'we need to
do whatever we can to protect an
intervention that is saving babies lives'.
Abdool Karim said one way out
would be to extend the 90-day period to
enable the  manufacturers to put
forward some other studies in
combination with the nevirapine study
and thus provide the MCC with the
'confirmatory evidence’ it was insisting
on.
If the MCC did de-register nevirapine,
the alternative would be that nevirapine
remain registered for use in other ways,
such as 'off label’, as was the case with
its use in post-exposure prophylaxis.
The government's prevention of
MTCT (PMTCT) nevirapine programme
has so far served an estimated 80 000
women and their babies.
Since the 'explosion' of  the HIV
epidemic in South Africa between 1994
and 1998, the incidence of HIV has
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stabilised but mortality is now rising
rapidly with more than 600 South
Africans of all ages dying daily of
AIDS-related diseases.
Mkhize said the 40 million HIV-
negative South Africans should be 'kept
that way as long as possible’, while the
5 million who were HIV positive should
be kept as healthy as long as possible
with key interventions being nutrition
and proper treatment of opportunistic
infections.
Deputy President, Jacob Zuma, told
delegates that the government was in
the process of finalising several
international agreements that would
provide access to medication and
ensure proper treatment. 'We need to
ensure that the necessary infrastructure
is in place, including laboratory support
and that we can ensure adherence and
supply support services,' he added.
Rejecting contentions that the
government was 'bent on genocide’, he
said the ANC had 'not come all this way
in fighting apartheid only to let AIDS
kill our people now'.
One of the country's leading AIDS
treatment activists, Judge Edwin
Cameron, pleaded with the government
not to 'fall into the mistake of
perfectionism'.
'We seized democracy in spite of
poverty and discrimination — we
mustn't disempower ourselves by
waiting for perfection now,' he warned.
He challenged Mkhize's assertion that
only 5 million people were living with
HIV, saying it affected 'every single
South African'.
The two hardest hitting speeches at
the conference's closing ceremony,
however, came from Mrs Prudence
Mabele, Director of the Positive
Women's Network (herself diagnosed
HIV positive in 1995), and Dr Kgosi
Letlape, chairman of SAMA.
Mabele lashed out at the
government's persistent contention that
local activists were influenced by
'outsiders with an agenda' and at
Tshabalala-Msimang's preoccupation
with 'olive oil and garlic'.
Almost in tears, she railed: 'how can
outsiders influence me? This is my life!
If I'm influenced by outsiders then we
were influenced by outsiders when we
put this government in place — we will
go anywhere and do anything to
survive. How many more people must
die?' she asked.
In a direct reference to the upcoming
elections, she added, 'we don't want to
wait until we must vote. The time is
now.You have forgotten us. I will go to
the streets if nobody helps me.’
Letlape, while welcoming the greater
mutual understanding and narrowing
of gaps in perceptions on crucial AIDS
issues, said that 'pseudo-science' had
been responsible for 'causing havoc' in
the country and confusing ordinary
citizens. 
He singled out stigma, a topic that
drew by far the biggest crowds in
presentation after presentation at the
conference.
Letlape said there seemed to be more
success in dealing with mosquitoes as a
vector of disease than with dismantling
the attitudes of vectors 'such as
inhuman males hiding behind couches'.
If South Africa failed to empower
women it would fail to survive as a
nation.'We need to deal with young
males who have this power in
relationships as young as at 14 years
old, or the disease will spread,' he
added.
Appealing for a 'can do' attitude in
fighting the pandemic, he said
indifference was 'as bad as being rich
and greedy'.
In one of the few references to
President Thabo Mbeki at the
conference, Letlape said political will
was a feature of countries which had
successfully tackled the epidemic. 
He added, 'the medical profession
humbly asks our president to lead us in
this fight. He's our president and can
lead the troops. The magnitude of this
problem requires him to lead us and we
will follow — he's a good president; the
world is watching us.’
Both Letlape and Mabele received
standing ovations.
All the leading speakers, from
government to NGOs, activists and the
country's top scientists, endorsed a call
by conference chairman, Professor Jerry
Coovadia, for a joint forum of all
stakeholders to meet regularly to tackle
the pandemic jointly.
Coovadia said the conference would
become an annual or bi-annual event.
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